Neuromultivit (Benfotiamine, Cyanocobalamin, Pyridoxine Hydrochloride)

Benfotiamine is a lipid‑soluble form of thiamine that readily enters cells and is converted to thiamine diphosphate. This co‑factor activates transketolase, helping to divert harmful glucose metabolites away from pathways that generate advanced glycation end‑products, thereby protecting nerves and blood vessels.

The appropriate dose of Neuromultivit is determined by the prescribing healthcare professional based on the individual’s clinical needs, age, and nutritional status. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Neuromultivit contains vitamins that are generally considered safe, but pregnant or breastfeeding individuals should consult their physician before starting the product to ensure the dosage and combination are appropriate for their specific situation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Neuromultivit combines three B‑vitamins in a single oral formulation, offering a convenient option for patients who need both thiamine‑derived support and B12/B6 supplementation. Compared with single‑ingredient products, it may reduce pill burden while delivering synergistic metabolic benefits.

Neuromultivit should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Neuromultivit is taken orally, usually with water. It can be taken with or without food, unless the prescribing clinician advises otherwise. Swallow the tablet or capsule whole; do not crush or chew unless instructed.

Serious risks, although rare, include allergic reactions such as rash, swelling, or anaphylaxis, and hematologic abnormalities like pancytopenia. Patients should seek immediate medical attention if they experience signs of a severe allergic response or unexplained blood‑related symptoms.

Individuals with known hypersensitivity to any of the ingredients, those with severe renal impairment without medical supervision, and patients taking medications that may interact significantly (e.g., high‑dose methotrexate) should avoid Neuromultivit unless cleared by a healthcare professional.